BSE •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 06/12/2026
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization27,052 mln
Float310 mln
Earnings Date08/06/2026
EPS
1.79
Moderate
P / E
28.02
Elevated
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-2.05
Caution advised
Relative Strength
95
/ 100
Top performer
Debt / Equity
0.17
Very low leverage
Business Description
Morepen Laboratories Limited is an India-based pharmaceutical company founded in 1984 that produces and sells drug ingredients, prescription and generic medicines, and consumer health products across India, the United States, and other global markets. Its product range covers treatments for conditions such as diabetes, high blood pressure, allergies, and digestive issues, alongside a broad line of home health devices including blood pressure monitors, glucose meters, and nebulizers. The company also sells everyday healthcare items under its Dr. Morepen brand, including products for fever, pain relief, and minor burns.